Beauty to rival Swarovski – protein crystals in CrystalSlide
Frickenhausen, [28 July 2009] – Greiner Bio-One GmbH has developed a new platform for the production and analysis of protein crystals. CrystalSlide for counter diffusion applications enables crystals to be analysed in an X-ray source and is also suitable for applications with polarised and UV light.
-
CELLview improves microscopic vision
Frickenhausen, [13 May, 2009] – The new CELLview product family developed by Greiner Bio-One GmbH combines the convenience of a standard plastic cell culture dish with the high optical quality of a glass bottom. This new development facilitates high-resolution microscopic imaging of in-vitro cultivated cells.
Reliable identification of frozen samples
Frickenhausen, [April 24th, 2009] – Greiner Bio-One GmbH is unveiling its new Datamatrix coding service for Cryo.s freezing vials at the 15th Annual Conference and Exhibition of the Society for Biomolecular Sciences, SBS, taking place in Lille, France, from 26 to 30 April.
Sensitive, specific and fast – external validation of CytoCheck mycoplasma test kit completed
Frickenhausen – [03/17/2009] - The international congress “2009 PDA, 3rd Workshop on Mycoplasmas”, to be held in Berlin from 24 to 26 March, offers scientists from the pharmaceutical and biotechnology industries, research institutes and external contract laboratories a platform to discuss new detection methods for mycoplasmas. Greiner Bio-One GmbH will be presenting its innovative DNA chip CytoCheck, which enables 40 mycoplasmas to be detected in cell cultures at species level.
Innovative surface leading to considerably higher cell yields
Frickenhausen, October 2008 – For the first time at Biotechnica 2008, Greiner Bio-One is presenting Advanced TC™ cell culture products with an innovative polymer modification. The special surface of the new product range optimises cultivation of fastidious cells and facilitates complex experimental approaches.
Stratec, Greiner Bio-One and Maven announce development co-operation for label free system solution
Birkenfeld July 28th, 2008 - Stratec Biomedical Systems AG, Birkenfeld, Germany, Greiner Bio-One GmbH, Frickenhausen, Germany and Maven Biotechnologies, Pasadena, CA, USA signed a first agreement regarding a joint development programme.
Strategic Cooperation between European ScreeningPort GmbH and Greiner Bio-One GmbH
European ScreeningPort, the European Centre for Drug Discovery, and Greiner Bio-One GmbH,
a leading international technology partner for the diagnostic and pharmaceutical industry, are
cooperating to optimise the screening process at ESP’s facility in Hamburg, Germany.
Large working volume – low dead volume: The new 384 Deep Well Small Volume™ Microplate
Frickenhausen, 06.02.2008 – Greiner Bio-One, internationally leading technology partner for the diagnostics and pharmaceutical industry, together with Boehringer Ingelheim, Biberach, has developed the 384 Deep Well Small Volume™ Microplate for reduced volume losses during sample storage and active substance tests.
Microplates with non-binding surfaces
Frickenhausen – Greiner Bio-One announced at Medica 2007 novel microplates with
an exceptionally high protein-repellent surface. The microplates developed at the
company optimise biochemical active substance screening in that the influence of the
plate surface on the test result is minimised.
Greiner Bio-One GmbH and CellMade S.A.S. agree on the joint development of cell biological products
Frickenhausen, 01/10/2007 – Greiner Bio-One GmbH, internationally leading technology partners to the diagnostic and pharmaceutical industry, and the French company CellMade are jointly publishing a new catalogue for products and solutions from the field of cell based research.
Invitrogen and Greiner Bio-One Team to Increase HPV Test Reliability
Carlsbad, Calif and Frickenhausen, Germany, June 25, 2007 – Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for disease research and drug discovery, and Greiner Bio-One, an internationally leading technology partner for the diagnostics and pharmaceutical industry, have finalized a licensing agreement to help improve the reliability of Greiner Bio-One’s HPV-DNA-test PapilloCheck® and DNA-array CytoCheck® products. The agreement covers the rights for the use of dUTP (deoxyuridine triphosphate) in PCR-based (polymerase chain reaction) methods to prevent sample contamination by amplification products in aerosols.
ThinCert™Plate optimises tissue reconstruction - The ThinCert™Plate is optimised for use with air-lift cultures and holds a substantially greater volume of cell culture medium than previous cell culture plates
HPV-Test PapilloCheck® is available immediately
Frickenhausen, March 2006 – Greiner Bio-One, the leading international technology partner for the diagnostic and pharmaceutical industry, is bringing the PapilloCheck® DNA-chip for the simultaneous genotyping of 24 different types of human papilloma virus (HPV) to market. The biochip is an In-vitro diagnostic tool for the qualitative detection of human papilloma viruses in clinical specimens. With it, medical laboratories and clinics will benefit from a specific identification of the causative agent for cervical carcinoma.
Greiner Bio-One: DNA-Chip CytoCheck® for quality assurance in the biopharmaceutical industry
Frickenhausen, 20 April 2006 - Greiner Bio-One GmbH, internationally leading technology partner for biotechnology, diagnostics and the pharmaceutical industry, will be at Analytica from April 25th to 28th, 2006 in München to bring their latest DNA microarray based diagnostic assay CytoCheck® to the market. The innovative DNA-chip detects mycoplasmas in biological materials, with identification to the species level, and has been developed for quality control in the biopharmaceutical industry.
Greiner Bio-One presents the unique cell culture AutoFlask™ designed solely for automated tissue culture
Frickenhausen, 05th April 2006 - An innovative cell culture flask for automated cell culture systems will be presented by Greiner Bio-One at the upcoming Analytica from 25th to 28th April 2006 in Munich. Developed by Greiner Bio-One, the leading international technology partner to the diagnostic and pharmaceutical industry, and the Genomics Institute of the Novartis Research Foundation (GNF), a leading innovator and producer of high-throughput automated research systems.
Greiner Bio-One's innovative MycoDtect™ diagnostic kit identifies mycoplasmas
Frickenhausen, 04. October 2005 - Greiner Bio-One GmbH, internationally leading technology partner for the diagnostic and pharmaceutical industry, is introducing their new development, MycoDtect™, onto the market at this years BioTechnica in Hannover. This innovative DNA-chip detects the presence of mycoplasmas in cell cultures and identifies the nine most common contaminating species. Detailed information about MycoDtect™ will be given in presentations from Greiner Bio-One at BioTechnica in Hall 2, Stand C24.
Greiner Bio-One and Scienion announce a novel solution for protein microarrays
Frickenhausen and Berlin, 12. September 2005 The cooperation partners Greiner Bio-One GmbH and Scienion AG have launched a new, integrated solution for protein microarrays. This novel development consists of a protocol and buffer system, which is specially designed for use with the HTASlides from Greiner Bio-One. The system allows the efficient production and analysis of protein microarrays. In addition, it is compatible with and enhances the already available HTAplatforms, which the cooperation partners have been jointly offering since the beginning of 2004.
Greiner Bio-One expands its product range with SensoPlate™ Plus
Frickenhausen, 6th June 2005 - Greiner Bio-One GmbH, leading international technology partner for the diagnostic and pharmaceutical industry, extends its programme with a completely new generation of glass bottom plates - SensoPlate™ Plus. The design of this novel development was achieved in cooperation with Evotec Technologies GmbH and is specially optimised for fluorescence correlation spectroscopy (FCS) and derived methods for single molecule detection (FCS+plus) as well as other advanced microscopy applications.
IVD-conformance confirmed for the ParoCheck® DNA-Chip
Frickenhausen, 10 May 2005 Greiner Bio-One GmbH, internationally leading technology partner for the diagnostic and pharmaceutical industry, has received confirmation of a complete and correct guideline-conformance rating for its Pa-roCheck® DNA-chip for the detection of periodontal pathogens. Specifically, the testing agency LGA InterCert GmbH in Nürnberg finds the chip in compliance with the European guideline for in-vitro diagnostics (IVD). Greiner Bio-One views this positive result as an important signal for the development of further biochips for the diagnostic market, as well as a milestone towards the certification of its innovative DNA-chip for the US-American market.
Greiner Bio-One BioScience established and successful world-wide
Frickenhausen, 11. April, 2005 Greiner Bio-One BioScience, a division of Greiner Bio-One International AG, has developed into an international leading technology partner for universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Despite the weak dollar, Greiner Bio-One BioScience, together with its sister company Preanalytics, was able to generate total sales revenues of 184.5 million in 2004. This represents an increase of 12.2 percent over the previous year. This significant performance reflects the successful efforts of its international sales and distribution network which ensures that its advanced solutions product programme is now available in nearly every country in the world.
Greiner Bio-One: 96 Well Half Area Microplates optimise sample volumes
Frickenhausen, 15. February 2005 Greiner Bio-One GmbH, internationally leading technology partner for the diagnostic and pharmaceutical industry and biotechnology, is bringing Half Area Microplates on the market as of February 2005, permitting a reduction of up to 50 per cent in the sample volumes in the 96 well microplate-format as compared to heretofore typical values.
Greiner Bio-One offers ultraflat lids for microplates
Frickenhausen, 19 January 2005 Greiner Bio-One GmbH, internationally leading technology partner for the diagnostic and pharmaceutical industry, is offering, as of January 2005, so called ultra low profile lids: universal, ultraflat lids, which are compatible with a variety of microplates. This novel development offers a reliable protection against evaporation, features a good barcode-readability and is optimised for automated processes.